| Logo | Name | Σ | Employees |
|---|---|---|---|
 | Start West ⭐️ The most promising innovative companies of the moment appear in front of investors 💸 Start West is the annual meeting of investors and innovative entrepreneurs in the West. For a day and an evening, they can meet for contact or to do business. entrepreneurship, investment, and startup Type: | 23 | N/A |
 |  Mines Paris - PSL Since its creation 240 years ago, Mines Paris - PSL has trained engineers and has produced essential knowledge to support companies to meet the challenges of their time. Originally those of mining extraction for the production of energy necessary for large industrializations, today those of ecological transitions and digital transformations. Founding member of PSL University, Mines Paris - PSL is a large, reference French engineering school and the first in partnership research. Type: | 64 | 1,121 |
 |  PANTERA A Better Fight for Life PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general. | 4 | 29 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 12 | 41 |
 | European Investment Bank (EIB) The EU Bank supports sustainable investment for people and the planet and works to improve lives. We provide finance and expertise for sustainable investment projects that contribute to EU policy objectives and make a strong impact on people’s lives in Europe and beyond. The EU's bank The EIB is the European Union's bank. We are the only bank owned by and representing the interests of the European Union Member States. We work closely with other EU institutions to implement EU policy. A major player As the largest multilateral borrower and lender by volume, we provide finance and expertise for sound … Type: | 199 | 4,773 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 13 | 162 |
 | Raidium The AGI radiology company [StartX P2025] Building the first Radiological Foundation Model for 3D medical imaging. artificial intelligence, radiology, medical imaging, and foundation model Type: | 23 | 22 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 79 | 20 |
 | iii - financements Non -dilutive financing levers Advice and expertise in non-dilutive funds (public and private funding): innovation, investment, international. Implementation in Paris, Nantes, Lyon, Bordeaux, Rouen, Marseille and Lille. Each year, more than 1,000 new businesses trust us with just as many customers who rely on us. We work on the long term with each company, because the overall funding strategy must be built over time. Help innovation, international aid, search for public funding, tax optimization, banking funding, international, Impacts, and calls for projects Type: | 76 | 121 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 170 |
 | BioLabs Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical Type: | 50 | 9 |
 | Almi We invest in future growth - corporate loans, venture capital and business development for companies that want to grow! Almi's job is to nourish you, so that you and your company can grow and flourish. Our job is to support and coach you. Our job is to offer expertise when you need it and fill the gaps in the market. We offer financing in the form of loans and venture capital as well as support and guidance in business development. For all companies with potential to have the same opportunities. Or as we put it: Nurture, which helps you grow. … Type: | 12 | 40 |
 | MGA Technologies Innovation, instruments, machines sur mesure et solutions digitales pour l'industrie du futur Our mission: design, develop and manufacture custom-made machines, innovative equipment and product lines for industries of the future. Our competencies: design, 3D CAD, automatisation and supvervision, robotics integration, clean room integration, numeric axis, marking, datamatrix, RFID, vision and controls.... References: Sanofi, Fresenius Medical Care, Boehringer Ingelheim, bioMérieux, L'Oréal, Valéo, Michelin, Schneider Electric, Becton Dickinson, ST Microelectronics, Staubli, ITEN, Buashc+Lomb, Xfab, EFI Automotive, STILLA, Soitec, Ceva, Symatese Device, Bobst, IPSEN, Medtronic, ABL Europe, Catalent, Pfizer, Clariant, Aguettant, Service de Santé des Armées... Robotics integration, Sterile flexible welders, Automated assembly … Type: | 59 | 102 |
 | Venionaire DealMatrix Transactions Made Easy. DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching | 48 | 7 |
 | European Circular Bioeconomy Fund (ECBF) A prosperous economy realigned with nature ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor. Our targeted investment sectors include new technologies and business models in Agtech; blue economy; and bio-based chemicals, … Type: | 20 | 32 |
 | In Extenso Innovation Croissance Consulting in strategic management of innovation and organizational transformation In Extenso Innovation Croissance supports innovative organizations on the major challenges of tomorrow by providing companies and public actors with the strategic vision of a partner capable of proposing and implementing scientific, technical, strategic, financial and fiscal recommendations in the field of sustainable innovation. With nearly 100 consultants mastering the entrepreneurial and sectoral challenges of their clients, In Extenso Innovation Croissance benefits from a strong territorial network, thanks to 8 regional offices, ensuring both reactivity and perfect knowledge of ecosystems and networks of decision-makers. In order to guarantee the quality of … Type: | 48 | 115 |
 | EntendsMoi Thanks to Verbatim.care, Act on the Improvement of Practices Thanks to the continuous analysis of the patient experience Co-founded by expert patients, healthcare professionals and an engineer, hearing his first digital solution Verbatim.care in co-development with 9 health establishments (CHU, GHT, ESPIC, Clinique, Center for the fight against cancer). Now deployed in more than 50 establishments in France and Belgium to act on improving professional and organizational practices thanks to the lived experience of patients, collected in their free comments. Patients' speech is transformed into levers of action thanks to automatic language processing (TAL) and allows precise, continuous and large … Type: | 28 | 5 |
 | La Financière de l'Echiquier Notre métier depuis 1991 : Investisseurs en entreprises Created in 1991, La Financière de l’Echiquier (LFDE) is one of France’s leading boutique asset management companies, with over €12billion in assets under management and a team of more than 130 employees. LFDE relies on its conviction-based management know-how to offer its institutional, distributor and private clients the responsible products and solutions they need to enhance their investments. LFDE is a subsidiary of the Primonial group, independent leader in France in the design, management and advice of investment solutions, and is also present in Switzerland, Italy, Germany, Austria, Spain and the Benelux … | 34 | 217 |
 | MATWIN French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de … Type: | 74 | 6 |
 | Arkhn We help Hospitalles Managing and Leveraging Their Data. 📣 We're hiring! Arkhn gives sovereignty to health establishments on their data, to better support patients, facilitate the work of caregivers and accelerate research. Created in 2019, Arkhn supports health establishments to manage their data permanently thanks to an interoperable data architecture which is deployed within the centers. This architecture makes it possible to aggregate, put in quality and standardize all health data and to facilitate access, in order to simplify the management of patients for medical teams. More broadly, it also promotes clinical research and health innovation, by offering effective and … Type: | 41 | 28 |
 | Sensome Sensitive Medical Devices Sensome is an innovative start-up developing a breakthrough sensing technology that can turn invasive medical devices into connected healthcare devices. Sensome is EN ISO 13485:2016 certified. Medical Devices, Connected Objects, MedTech, and Neurovascular Type: | 17 | 41 |
 | IBA IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered to be the most advanced form of radiation therapy available today, industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance. Proton Therapy, RadioPharma Solutions, Dosimetry, and Industrial Solutions Type: | 4 | 2,916 |
 | Debiopharm we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university … Type: | 15 | 488 |
 | IMBC SME financial partner IMBC (Invest Mons-Borinage-Center) is an actor of private law active in high balance sheet funding (venture capital) and support for SMEs, start-ups, spin-out and spin-off. Imbc offers financing solutions adapted to the needs of companies at any stage of life: from creation to transmission. Active for more than 30 years, the group has intervened for the benefit of more than 1,225 companies including 350 still in the portfolio. Venture Capital, SME, Start-ups, Investments, Loan, Risk Investments, Equity, Investment Facilitation, Spin-Off, Entrepreneurship, Family Business, Growth, Innovation, Success Story, Enterprise, Funding, and Wallonia Type: | 16 | 19 |
 | Germitec UV-C High-Level Disinfection for endocavitary and external ultrasound probes Germitec’s mission is to improve the standard of care by reducing cross-contamination risk and offering healthcare professionals with an automated solution that is fast, simple, safe, and environmentally friendly. Our products uses patented Yuvee® UV-C technology to provide High-Level Disinfection (HLD) for endocavitary and external ultrasound probes. ultrasound, disinfection, highleveldisinfection, infectioncontrol, ultraviolet, UVC, HLD, transducers, HPV, hightech, medtech, greentech, cleantech, frenchtech, healthtech, innovation, patientsafety, and infectionprevention Type: | 14 | 67 |
 | Omnidoc The tele -expertise platform which facilitates and values medical collaboration Omnidoc is a tele -expertise solution for liberal doctors and health establishments. Omnidoc makes it possible to secure, trace and financially enhance the opinions exchanged between doctors. It offers the opportunity to better sort and prioritize requests for care, strengthen the links between correspondents or city / hospital and improve the care path of patients. Type: | 6 | 44 |
 | Coave Therapeutics Coave therapeutics Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success … Type: | 9 | 41 |
 | SFPIM Federal Holding and Investment Company (Federale Participatie- en Investeringsmaatschappij / Société Fédérale de Participations et d'Investissement) was created on 1 November 2006 as a result of the merger between the Federal Participation Company and the Federal Investment Company, two public holding companies that each have their own history. The federal government is the sole shareholder in the Federal Holding and Investment Company. The Federal Holding and Investment Company (FHIC) centrally manages the federal government's shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy. The FHIC has three core … | 23 | 54 |
 | Volotea Connecting Volotea Cities Volotea, the airline of Europe's medium-sized cities, was founded in 2011 and is one of the fastest-growing independent airlines in Europe. It reaches over 110 airports and is currently based in 21 European regional capitals. This year it plans to operate nearly 450 routes, offer between 12.5M to 13M seats, and operate around 80,000 flights. The company is committed to sustainable aviation and has launched over 50 initiatives to reduce carbon emissions. Skytrax has consecutively recognized Volotea as the 'Best Low-Cost Airline in Europe' in 2023 and 2024 based on its global passenger satisfaction survey. Travel, Transportation, … Type: | 11 | 1,593 |
 | Ulysse Communication Who better than former journalists to make your voice heard? Ulysses Communication, at the crossroads of press and communication. Specializing in press relations and financial communication, Ulysse Communication was created by former economic and financial journalists who have themselves surrounded by former journalists. The agency and the team are strongly marked by this DNA which results in an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic world and businesses. Press relations, financial communication, finance, listed company, Introduction on the stock market, financial operations, public relations, corporate communication, asset management, real … Type: | 65 | 16 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: | 8 | 38 |
 | Chiesi Group Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. … Type: | 14 | 5,725 |
 | Sygnature Discovery Sygnature Discovery is a world-leading integrated drug discovery contract research organization based in the UK and Canada with headquarters in Nottingham (UK). Additional sites are located in Alderley Park, Macclesfield, and Glasgow (UK), as well as Montreal and Quebec City (Canada). Its team of over 1,000 employees, which includes 900 scientists, partners with global biotech, pharma and NFP organizations. Since 2011, Sygnature Discovery has delivered 50 novel pre-clinical and 30 clinical compounds, with its scientists named on over 170 patents. Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases, and more. Founded in … Type: | 15 | 664 |
 | SISTA Bring out a generation of leaders by reducing inequalities in funding between women and men Sista is a collective of women entrepreneurs and investors who promotes more diversity in the digital economy by encouraging in particular more investments in companies led by women. In partnership with all stakeholders in the ecosystem, the collective co-constructed good practices in order to fight against unconscious biases and bring out a generation of more diverse leaders. Created in December 2018, the collective is led by Céline Lazorthes, Tatiana Jama, Valentine de Lasteyrie and her board is composed of Nathalie Balla (La Redoute & Amp; … Type: | 138 | 109 |
 | Poppins Health and reeducation through music 🎶 Mila is an early-stage social technology venture focused on helping through music. Our flagship product is a rehabilitation tool for learning and language disabilities that we develop in collaboration with speech therapists and neurologists. For this purpose, we create awesome technology to deliver a personalized and effective musical activity experience. Not just listening to sound: also activities, exercises, and interactions. Software design, Neuroscience, Music, Learning disabilities, Adaptative Learning, Data sciences, Health, Education, and Dyslexia | 28 | 66 |
 |  Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: | 7 | 11 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 34 | 56 |
 | NaoX Technologies A laboratory in the ear Naox Technologies is a French startup launched in 2018 by Hugo Dinh, Polytechnician and Michel Le Van Quyen, expert in neuroscience at Inserm. Our mission is to democratize the prevention of neurological disorders. Neuroscience, IoT, and Health & Amp; Well-being Type: | 20 | 20 |
 | Orakl Oncology Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 30 | 20 |
 | AI for Health We connect public and private actors in the Artificial Intelligence and the Healthcare Industry AI for Health's mission is to bring together the ecosystems of Artificial Intelligence and Health to support the ambition of the national strategy for Artificial Intelligence inHealth. It is essential to invest and mobilize now, in order to fully seize the opportunities that Artificial Intelligence offers to revolutionize the health sector." These future opportunities are clear: to increase access to care, quality of life and healthy life expectancy for the world's population. This will only be possible if the world of health opens up to other … Type: | 73 | 9 |
 | Hy24 Hy24 is the world's first investment manager fully dedicated to scaling up the clean hydrogen economy. Hy24 is a joint venture between Ardian, Europe’s largest private investment house with managed assets of c. $164 billion, and FiveT Hydrogen, the first pure-play low-carbon hydrogen private investment and asset management platform. We combine Ardian’s premier infrastructure fund management record with FiveT’s unparalleled hydrogen expertise and network. We will scale up the global hydrogen economy through first-mover investment opportunities perfectly aligned with the universal ESG agenda. clean hydrogen, infrastructure, industry, mobility, hydrogen economy, asset management, finance , and ESG Type: | 59 | 48 |
 | BioPharmAnalyses Biopharmalysis is an information site that allows you to make an active watch and follow the strategic developments of companies in the biopharmaceutical sector. With biopharmalysis: • You get a synthetic view of recent news from the sector • You are aware of the latest key agreements and mergers and acquisitions • You follow the clinical and regulatory progress of development products • You have access to the latest subsidies, fundraising and IPOs on the stock market Its five databases have more than 13,000 interactive sheets on agreements, clinical trials, fundraising, mergers/acquisitions and the regulatory life of biopharmaceutical products in … Type: | 16 | 2 |
 | Leavy.co Live Anywhere Founded in 2017 & launched in 2018, Leavy.co is a young French scale-up already spotted as Europe’s answer to Airbnb. On a clear mission to unlock travel for everyone, our platform gets straight to the point: we pay directly, in advance & within 24 hours, users willing to share their homes or care for fellow travellers. Within 18 months, we opened offices in Paris, Amsterdam, London, Madrid, Rome, and Lisbon. Today we are active in 83 cities! Join Leavy today, travel the world with us and bring your next trip a little closer! Travel, Mobility, Community, DeepTech, Marketplace, … Type: | 10 | 19 |
 | Speedinvest Game-changing support for early-stage tech founders from our focused investment teams and in-house operational experts. Speedinvest is one of Europe’s most active early-stage investors with more than €1 billion AuM and 30+ investors based in Berlin, London, Munich, Paris, and Vienna. Founder success is our top priority, so we don’t just send some money and "check-in" at board meetings. Our mission is to empower you with game-changing support through every stage of your journey. Our focused investment teams know your industry inside and out. Their proven experience, know-how, and deep networks are yours from day one. You also have full … Type: | 148 | 131 |
 | Olivier Millet Member of the Executive Board @Eurazeo, @Eurrazeopme, Member of Ca @Europlace, Ex Mer Executive Committee @medef, former president @franceinveteu #privateequity #PME #ETI #esg | 12 | 28 |
 | Provence Angels Invest and invest alongside entrepreneurs Provence Business Angels is an association (1901 law) which was created in September 2007. The network brings together around fifty members with diversified profiles in terms of qualifications and experiences. Members have for the most part a journey of entrepreneurs or executives. They now want to use their experiences to support the start of young companies. Provence Business Angels finance and mainly support companies with high growth potential. Its action supports the regional economy and job creation. Provence Business Angels intervenes in companies at the start stadium, that is to say at a development period … Type: | 67 | 41 |
 | Solence Digital program to support women with PCOS beyond the pill. Our app is available on Apple Store and Google Play. Solence delivers an evidence-based program with interactive lessons to learn how to reverse PCOS symptoms with lifestyle changes, and a PCOS assessment toolbox to map symptoms triggering factors. Learn more about our app here : https://apps.apple.com/fr/app/solence-sopk/id6450059867 Healthtech, Femtech, Deeptech, Womenshealth, and Digital therapeutics Type: | 16 | 3 |
 | Kickston Fundraising i m & amp; a Kickston is a business bank that supports entrepreneurs in their fundraising and amp; a. Industries: Consumer & amp; Tech B2B • Fund lifting: 2 to 10M € • Cession: operations up to 15M € Are you interested in our approach? Contact us! contact@kickston.co Type: | 36 | 8 |
 | SHARPSTONE Innovation financing advice and investor in SEED Sharpstone has developed an original and innovative approach by combining a consulting offer, Sharpstone Advisory (innovation financing) and an investment offer, Sharpstone Capital (SEED VC for technological startups). Concretely, Sharpstone Advisory is a decompartmental, financial and operational consulting firm, which can be summed up in 3 keywords: #Technologies, #Finance, #business. But, it is also and above all, a team of passionate and enthusiastic entrepreneurs. Strategic and financial advice, advice in improvement in economic performance, restructuring consulting, and non-dilutive financing Type: | 25 | 42 |
 | secpho We accelerate innovation through Deep Tech We are SECPHO, a technological innovation cluster formed by companies, technology centers and research groups, experts in Deep Tech, who firmly believe in collaboration. SECPHO is focused on promoting technological innovation by applying the DEEP TEC to all types of sectors of our economy. The main objectives of the cluster are: • Generate business opportunities for companies. • Facilitate access to projects, both national and international, for technology centers and research groups. • Promote innovation in the field of Deep Tech. These benefits are transferred to the partners through different actions such as Networking … Type: | 24 | 13 |
 | FUSACQ FUSACQ is a marketplace dedicated to mergers and acquisitions experts, investment funds and private investors, legal and natural persons, and business leaders wishing to sell their business. 1 company sells every day thanks to the portal (https://www.fusacq.com) which offers: Services to promote operations of transmission recovery - 2500 ads of companies for sale or in search of acquisition - 2000 investment fund participation - 450 hp of natural person buyers - 600 experts working on all stages of an operation - Training in business resumption and external growth - a business valuation base All the news of the mergers acquisitions … Type: | 113 | 12 |
 | Charles.co Charles is a digital clinic that helps his patients solve their chronic problems (sexo, sleep, hair) Charles helps you regain control over your daily health concerns, starting with intimate health, sleep disorders, hair loss and soon digestion problems. Male health, health, and digital health Type: | 3 | 18 |
 | Spotlight Medical A precision medicine company solving the critical issue of inadequate cancer treatments Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improving patient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care. Founded in 2024, Spotlight Medical is backed by Institut Curie and … Type: | 4 | 4 |
 | EQT Life Sciences EQT Life Sciences (formerly LSP) is one of Europe’s largest and most experienced healthcare investors. EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. Investment Firm, Healthcare, Biotechnology, Fund Management, Life Sciences, Venture Capital, Private Equity, ESG, and Impact Investing Type: | 14 | 27 |
 | TVM Capital Life Science Leading international VC providing capital and expertise to support breakthrough therapies and medical products TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global … Type: | 7 | 44 |
 | Bayern Kapital Committed to high-tech & deep-tech Committed to high-tech and deeptech. As a hub of technology and innovation within Germany, Bavaria is one of the premier locations for up-and-coming high-tech companies and venture capital professionals in Europe. Since 1995 Bayern Kapital have been supporting young, Bavarian technology companies competently and patiently with venture and growth capital and access to a wide-reaching network. From seed phase to exit or IPO and during growth, scale-up, expansion and internationalization – we support Bavarian innovators in turning their business idea into an internationally successful business. Are you an entrepreneur? With ticket sizes of up to … Type: | 23 | 48 |
 | Parc Científic de Barcelona Where Science becomes Business The Barcelona Science Park is one of the leading ecosystems in Europe in research, technology transfer and innovation with more than 100,000m2 built and around 3,453 professionals working in 120 entities mainly in the health sector: pharmaceuticals, biotechnology, medical technologies, food and cosmetics. | 37 | 109 |
 | European Pharmaceutical Manufacturer A leading publisher in the pharma/biopharma manufacturing industries. European Pharmaceutical Manufacturer is a leading publisher covering the pharma/biopharma manufacturing supply chain from formulation to distribution, keeping readers informed of the latest news, opinions, developments and breakthroughs in this innovative and technologically advanced sector. Our portfolio consists of a monthly printed & digital magazine, online news source, weekly newsletters and active social media channels, not to mention regular contributions to The MedTalk Podcast. pharmaceuticalmanufacturer.media | @EPM_Magazine | #MedTalk Pharma, Manufacturing, Publishing, Medtech, and B2B Type: | 54 | 10 |
 | IPEM Meaningful Connections for Private Markets IPEM Cannes | Wealth 2025 Jan. 28-30, Palais des Festivals, Cannes, France. IPEM, International Private Equity Market, is the premier relationship broker for global private equity. It brings together the entire private equity ecosystem, facilitating connections and knowledge-sharing through a range of channels. Attendees can connect in person at events such as exhibitions, networking sessions, and conferences, and stay informed throughout the year via the IPEM website and LinkedIn page. Additionally, the IPEM platform offers access to exclusive reports and online services such as pre-networking and matchmaking recommendations. In only 8 years, IPEM has become … Type: | 77 | 6 |
 | Techmind We leverage a network of super investors to invest in ambitious startups through in a very selective process. Techmind is a firm created in 2018, dedicated to Venture Capital investment. Invest directly into the best startups ! Our clients are : - family offices investing into startups and looking for a professional support on startup sourcing, deal negotiation and portfolio management, - business angels willing to access to exclusive and high selective club deals, - companies, willing to accelerate their transformation by investing into high potential startups, Our team is based in Paris and in Nice, but we look at … Type: | 23 | 18 |
 | Andrew Lloyd & Associates International PR group | Market communications for life sciences & tech 🚀 Andrew Lloyd & Associates is an international public relations consulting group for leading edge companies and organizations involved in emerging technologies. ALA has its own offices in the United Kingdom and France, as well as a network of collaborators, individuals and companies, throughout Europe and the US. ALA has been active across Europe since 1987 and has the experience and know-how to provide seamless and scalable services in one or many EU countries and the US Andrew Lloyd & Associates is active in technical, business, financial and scientific … Type: | 69 | 9 |
 | Paris-Saclay SPRING May 12,13, 2022 | Come & discover Europe’s Number 1️ INNOVATION ECOSYSTEM! Produced in partnership with @VivaTech All those involved in innovation, research, science and economic development have come together, one more time, to cast a spotlight on the technological innovations and scientific achievements that are made here every day. Accounting for 40% of public research and private R&D undertaken in Ile-de-France, the Paris-Saclay innovation cluster is undoubtedly at the forefront of French innovation. Innovation, FoodTech, GreenTech , Mobilités, Santé-Biotech , and Technologies Numériques Type: | 91 | 1 |
 | Alven Heart-led venture capital for global game changers Alven is an independent early-stage venture capital firm with over $500m under management and a successful track record of backing more than 130 startups over 20 years. Our mission at Alven consists in supporting the long-term success of European category-defining startups with global reach, starting at Series A or Seed stage. Alven’s sectors of interest include notably B2C/B2B marketplaces, productivity and dev tools, vertical AI platforms, consumer social & entertainment, B2C financial services and wellness brands. Examples of past or current investments PRODUCTIVITY SOFTWARE: Akeneo - Bime Analytics - Dataiku - Georges.tech - … Type: | 46 | 32 |
 | Voxdale | design-driven engineering Specialized in design-driven engineering services that ensure manufacturability and product success. Introducing Voxdale: your product development partner for success and innovation. In today’s competitive market, your hardware challenges need bold, innovative, and high-performing solutions. That’s where we come in. At Voxdale, we’ve spent nearly two decades designing and developing products to meet the specific business and consumer needs of start-ups, scale-ups, and multinational companies. Our creative team of experts, designers, and engineers will put your ideas through state-of-the-art simulations and prototyping to accelerate their development. The end result? Products that wow. With Voxdale on your team, you’ll be supported at … Type: | 9 | 38 |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 16 | 18 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 54 | 59 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 51 | 17 |
 | SCK CEN Exploring a better tomorrow Do not underestimate the power of atoms: nuclear applications can make a great difference for society both now and in the future. This is why as one of the biggest research centres in Belgium we continue to perform groundbreaking research. SCK CEN is a global leader in the field of nuclear research, services and education. With more than 900 employees, throughout all of our work, we are focusing on 6 research topics: • Health • Environment • Society • Materials • Technology • Safety These are our building blocks for developing innovative applications for society. In … Type: | 9 | 865 |
 | Angels Santé The leading European Business Angels network in healthcare investment Europe’s number one Business Angel Network for Health Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development. Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects. Our members invest in healthcare projects that they understand, thanks to their expertise and … Type: | 75 | 71 |
 | ICEX Do you want to boost your company in international markets and increase your competitiveness? At ICEX we can help you. ICEX is the main Spanish internationalisation organisation. We are dedicated to promoting trade and investment between Spain and other countries. We work all over the world, covering all sectors and helping companies of all kinds. We work closely with the autonomous communities to attract foreign direct investment. The integration of the public and private sectors is an essential characteristic of our DNA. We provide services through a network of 31 Provincial and Territorial Trade Directorates in Spain and 104 Economic … Type: | 48 | 862 |
 | PMV Financing solutions for every promising company or project with a good business plan PMV is a Flemish investment company that invests in the future of the Flemish economy. We finance promising companies and projects from the very beginning to growth and internationalization. In addition, we provide financial customization for all entrepreneurs with a sound plan and a good team. To this end, our one hundred and twenty-five professional employees draw on our proven arsenal of capital, loans and guarantees. With more than one billion euros in assets to invest, we are a powerful investment company that fully supports your ambitions. … Type: | 17 | 1,003 |
 | Protéines France Association œuvrant pour le développement du secteur des protéines végétales et des nouvelles ressources Protéines France is the French consortium of enterprises whose ambition is to federate and catalyse the development of innovative. Protéines France aims to speed up the development of the plant-based and alternative protein sector in order to seize the opportunities for growth and job creation offered by the global increase in the demand for proteins and thus to make France a world protein leader. PROTEINES FRANCE *We focus on innovative proteins: plant-based and alternative sources (insects, algae, microorganisms...) *We bring together the major French innovative proteins … Type: | 44 | 2 |
 | Villa M Villa M is a unique concept for the world dedicated to the health of tomorrow, in the heart of the 15th arrondissement of Paris. This holistic haven was created by Groupe Pasteur Mutualité for all health professionals and for all those who make their health and well-being a priority. It brings together a prevention and care center, a boxing club & amp; Fitness, meeting and training rooms, an innovation showroom, a hotel and a restaurant. Since its opening, Villa has become the benchmark for Parisian health events. Villa M is a place of sharing, discoveries and meetings for all the … Type: | 14 | 45 |
 | 2CFinance Independent financial consulting firm, specialized in the Services Transaction and the DAF Part Time Our mission: "Advise investors and managers to diagnose and improve the quality and performance of business financial departments". • Consulting company, based in Paris 9th, in Aix-en-Provence and Nantes. • Two professions: delegated operational financial management and the financial council. • A team of 50 employees. • More than 500 missions conducted in Small and Midcap companies, with respect for absolute discretion and confidentiality. • A portfolio of renowned entrepreneurs, managers and investment funds. • A long experience of supporting companies in different key phases of … | 69 | 111 |
 | mind Health The strategic information media devoted to the digital transformation of health industries. Mind Health is a media of strategic information which offers every day a watchtower of the news in the health sector and each week of the articles of analysis searched and enriched by data. Its mission is to decipher the transformations of the sector and the health industries through its economic, technological, regulatory and political issues. Mind Health is aimed at all players in the value chain in the health ecosystem: pharmaceutical industry and medical, electronics, computer and telecoms, mutual and insurance, public and private care providers, service … Type: | 91 | 9 |
 | COFIDES Compañía Española de Financiación del Desarrollo, COFIDES S.A., S.M.E. COFIDES es una sociedad mercantil estatal que gestiona fondos financieros del Estado, así como recursos propios y de terceras instituciones con distintos objetivos: la internacionalización de la economía española, la atracción de inversión extranjera a sectores estratégicos en España, la promoción de la economía de impacto en España y la contribución al desarrollo de los países en los que invierte. En su accionariado, además del Estado, que ostenta una posición mayoritaria, participan el Banco Santander, Banco Bilbao Vizcaya Argentaria (BBVA), Banco Sabadell y CAF-Banco de Desarrollo de América Latina. Más información: … Type: | 21 | 131 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … Tags: FrenchTech120 FrenchTech2030 Type: | 49 | 174 |
 | Creathor Ventures Backing the creators of our future. Creathor Ventures invests in technology-oriented companies that drive the automation of industry and business, and the personalization and digitalization of healthcare. The regional focus is on Germany and Switzerland. From its locations in Bad Homburg and Zurich, the team currently supports over 30 tech and healthcare companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros. Venture Capital | 13 | 7 |
 | Casdin Capital, LLC Life Science Investments Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we … Type: | 6 | 47 |
 | Atomico The founder-built European VC. We partner with the most ambitious entrepreneurs using tech to rewire the world, better Atomico is the founder-built European venture capital firm. We partner with the most ambitious entrepreneurs using technology to rewire the world, better. Skype co-founder Niklas Zennström launched Atomico in 2006 with the belief that entrepreneurs are the ultimate gamechangers for positive transformation across the most critical aspects of our society and economy. Starting in Europe, the firm’s mission is to further their global progress, with a platform offering unmatched support from the early stage to scale. 130 of Europe’s most ambitious founders … Type: | 123 | 145 |
 | EuroQuity - Bpifrance Shine Match & Deal EuroQuity is a service by Bpifrance, France's national investment bank, financing businesses through loans, guarantees, equity investments, and export insurances. Created in 2008, EuroQuity is an online matchmaking platform that helps companies meet investors and partners. EuroQuity is one of the leading matchmaking platforms in Europe while becoming increasingly present in Africa. We provide many additional services such as acceleration programs funded by the European Commission, digital training, coaching sessions, and exclusive online pitch sessions for the most promising companies. In short, EuroQuity is the perfect match for companies to scale with confidence and speed and … Type: | 55 | 2 |
 | Hopia Medical schedules & amp; Paramedics optimized by IA Agoranov | Parisian Campus | 21st power plants Hopia is the automated planning solution capable of integrating all the rules - collective, legal and individual - to offer a fair and optimal schedule in the blink of an eye. Our mission? Free up time for caregivers and doctors to allow them to focus on their profession: treating and saving lives. The first solution developed by Hopia focuses on human resources planning. It centralizes all the creation and management of the schedules of doctors and caregivers. It is based on algorithms - exceeding … Type: | 25 | 25 |
 | Ganymed Robotics Orthopedics for visionaries There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. It's going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldn't be a direct result of the surgeon's state of mind. We believe it's possible to create tools that will improve both patient … Tags: FrenchTech2030 Type: | 22 | 42 |
 | Stilla Technologies Discover the Sensitivity & Simplicity of Multiplex Crystal Digital PCRTM Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCRTM technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world's first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for … Type: | 15 | 108 |
 | Andera Partners The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage €4.3 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion/Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our teams, based on … Type: | 48 | 139 |
 | Artefact We are a global leader in data transformation services and data marketing to drive business value across organizations. Artefact is a leading global consulting company dedicated to accelerating the adoption of data and AI to positively impact people and organizations. We specialize in data transformation and data marketing to drive tangible business results across the entire enterprise value chain. Our 1500 employees operate in 23 countries (Europe, Americas, Asia, Middle East Africa) and we partner with 1000 clients, including 300 major brands like Samsung, L’Oréal, Orange and Sanofi. We provide customized services from strategy to operations: data strategy, data quality … Type: | 108 | 6 |
 | KLODIOS The collective intelligence platform in healthcare ❔ KLODIOS is a platform which, thanks to its AI, gathers in one place and suggests news, knowledge in health in a simple, fast and secure way. We are convinced that all health professionals - health authorities, industry, associations - deserve a space to share information. ❕ Every day, caregivers face a multiplicity of sources to find answers, they lose time. This time is not devoted to patients. 💬 We firmly believe in collective intelligence, in a community and interdisciplinary approach to health. 🩺 KLODIOS is the collective intelligence platform in health. santé, information, … Type: | 20 | 3 |
 | First Bridge Ventures First Bridge Ventures is a platform designed to connect the Asian and European Tech and lifestyle landscapes. Type: | 1 | 12 |
 | baby vc Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓 venture capital, bootcamp, … Type: | 80 | 189 |
 | Turenne Groupe Support the development of value -creating companies by investing in a professional and responsible manner. Leader independent of Small Cap capital-investment capital in France, Turenne Groupe has supported entrepreneurs for 25 years in their innovation, development and transmission projects of their company throughout the territory. With more than 2 billion euros in assets under management and 300+ companies in the portfolio, Turenne Groupe relies on sectoral expertise and dedicated teams in the health sectors, environmental services, industrial startups and Deeptech, the hotel industry. Present throughout France with 7 regional locations in Paris, Lille, Lyon, Marseille, Nice, Bordeaux and Nantes, Turenne … Type: | 53 | 93 |
 | Multeam Advice in fundraising, transfer and acquisition Multeam has supported businesses in their fundraising and sales-acquisition operations for more than fifteen years. We process fundraising operations from € 1 million to 20M € in all sectors of activity except biotechnologies. We also support managers in their transactions of sale and acquisition in Small and Mid Cap. +100 operations carried out. Fundraising, Venture Capital, Investment Capital, Financial Services, and Fundraising Type: | 25 | 5 |
 | JEITO Go faster for the Patient, further with the Entrepreneur Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower and support entrepreneurs through our expert, integrated, multi-talented team. Jeito Capital is based in Paris with a presence in Europe and the United States. Follow us to get our latest news & job offers. Private equity and Biopharma Type: | 49 | 36 |
 | Tacalyx GmbH Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need Type: | 3 | 13 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 3 | 17 |
 | Alpha Intelligence Capital Alpha Intelligence Capital (AIC) is an entrepreneurs-led, entrepreneurs-invested, global closed-end private venture capital fund. We invest in Seed to Series B, deep Artificial Intelligence/Machine Learning (AI/ML) technology-based companies. We invest in teams applying deep expertise in the algorithmic sciences to develop breakthrough products and solve real business problems. AI, Artificial Intelligence, Venture Capital, Fund, Partnership, Machine Learning, Deep Learning, Investment, Deep Learning, Computer Vision, Cyber Risk, Robotics Automation, ASICs, Reinforcement Learning, and Quantum Computing Type: | 21 | 24 |
 | Institut Imagine Institut Imagine, pour guérir les maladies génétiques. Institut Imagine for genetic disease is a French translational research institute which performs state-of-the-art research in order to better understand genetic diseases. The Institute brings together scientists and physicians around the patients in a unique, ultra-modern 19,000 sqm building located within Necker Children’s Hospital, Paris. The teams also benefit from cutting-edge technological platforms and clinical facilities providing methodological advice as well as huge and rationalized cohorts of patients. The objective is to foster translational research and accelerate the development of new therapeutic and diagnostic solutions for the ultimate benefit of the patients and … Type: | 56 | 453 |
 | Supernova Invest European deeptech VC, focused on high-growing start-ups and cutting-edge technologies Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and patient capital in the fields of Digital, Industrial Technologies, Healthcare and Cleantech to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Alice & Bob, Gleamer, Sonivie, UnitySC, Unseenlabs, Loft Orbital or ANYbotics. The Supernova team exited +25 companies through top IPO and M&A deals. The team is composed of +20 experienced investors with a unique ability to understand both the underlying technologies and the … Type: | 93 | 39 |
 | IRIS What's next IRIS is a leading venture capital and growth firm investing in tech platforms in Seed, series A, Late-stage and Growth. Our team of local experts based in Berlin, Munich and Paris has invested over a billion euros in more than 350 innovative companies across the world. The IRIS team supports disruptive tech companies like Shift, Kyriba, LeanIX, Forto, Exotec, Escape, Jedox, Virtuo, Zeta Global, Spinergie and many more. Want to talk to our team? Don't hesitate to send us your deck on www.iris.vc/submit-a-project Type: | 93 | 79 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Venture Capital, Private Equity, Co-Investment, Tech, IA, Impact, Europe, Early Stage, and Growth Type: | 96 | 22 |
 | Inserm Transfert Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of … Type: | 76 | 122 |
Event